ARCHIVES

Taxol Plus Carboplatin Increased Survival Of NSCLC In Patients 70 And Older

This article is from The Cancer Letter archive.

Vol. 33 No. 6 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

ODAC Member Critical Of Amgen For Price Incentives.

March 21, 2008

ASCO, ASH Issue Guidelines On Use Of Epo For Anemia

October 25, 2002

U. S. Oncologists To Audit Another Bezwoda Trial.

November 10, 2000

In Brief: San Antonia Cancer Institute Designated Comprehensive; Yeast DNA Described

May 3, 1996

BMI May Be Prognostic Tool For Types Of Breast Cancer

March 28, 2008

An “insurgency” targets randomized trials, demands access to investigational drugs.

August 5, 2005